Allometric Dose Retranslation Unveiled Substantial Immunological Side Effects of Granulocyte Colony–Stimulating Factor After Stroke
Author(s) -
DanielChristoph Wagner,
Claudia Pösel,
Isabell Schulz,
Gerda Schicht,
Johannes Boltze,
Franziska Lange,
Johanna Scheibe,
Karoline Möller,
Gesa Weise
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.003812
Subject(s) - medicine , stroke (engine) , spleen , granulocyte colony stimulating factor , neuroprotection , immune system , granulocyte , flow cytometry , immunology , pharmacology , chemotherapy , mechanical engineering , engineering
Granulocyte colony-stimulating factor (GCSF) showed robust neuroprotective and neuroregenerative properties after stroke in rodents but failed to meet study end points in patients. Because immunologic side effects of GCSF may have escaped preclinical testing because of nonallometric dose translation, we hypothesized those as possible reasons.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom